Small cell lung cancer (SCLC), one of the deadliest types of lung cancer, is an aggressive tumor that metastasizes early compared to other cancers and can quickly develop resistance to chemotherapy — ...

Scientists at the University of Minnesota's Hormel Institute in Austin recently published a study that looked at a drug that ...

Dopamine doesn’t flood the brain as once believed – it fires in exact, ultra-fast bursts that target specific neurons. The ...

A finding by a McGill-led team of neuroscientists could open doors to new treatments for a range of psychiatric and ...

Dopamine agonists, although considered the first-line agents in management of moderate-to-severe RLS, are not without adverse effects, the most common being nausea, dizziness, ...

Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today ...

Access free, up-to-date clinical references on dopamine receptor agonists at Healio. We aid in making confident point-of-care decisions for type 2 diabetes.